Trial intelligence / Profile preview

Coenzyme Q10 in ischemic stroke

IRCT20210907052400N1Phase 3Completed

Sponsor
Hamadan University of Medical Sciences
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of coenzyme q10 in ischemic stroke, sponsored by Hamadan University of Medical Sciences. Started Oct 2021; status: completed.

02

Drugs

coenzyme q10
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on IRCT20210907052400N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210907052400N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call